Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroglia | 6 | 2025 | 215 | 2.790 |
Why?
|
| C9orf72 Protein | 6 | 2019 | 51 | 2.630 |
Why?
|
| Lipid Droplets | 4 | 2025 | 51 | 2.120 |
Why?
|
| DNA Repeat Expansion | 6 | 2019 | 79 | 1.660 |
Why?
|
| Frontotemporal Dementia | 5 | 2019 | 74 | 1.580 |
Why?
|
| Amyotrophic Lateral Sclerosis | 5 | 2019 | 193 | 1.430 |
Why?
|
| Alzheimer Disease | 5 | 2025 | 880 | 1.300 |
Why?
|
| Neurons | 9 | 2025 | 2049 | 0.990 |
Why?
|
| tau Proteins | 2 | 2025 | 240 | 0.940 |
Why?
|
| Lipid Metabolism | 2 | 2024 | 388 | 0.880 |
Why?
|
| Sleep | 2 | 2024 | 370 | 0.870 |
Why?
|
| Oxidative Stress | 2 | 2024 | 877 | 0.730 |
Why?
|
| beta Karyopherins | 1 | 2021 | 15 | 0.730 |
Why?
|
| ran GTP-Binding Protein | 1 | 2021 | 29 | 0.730 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2021 | 33 | 0.720 |
Why?
|
| Karyopherins | 1 | 2021 | 40 | 0.710 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2021 | 71 | 0.690 |
Why?
|
| Dipeptides | 3 | 2019 | 64 | 0.670 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2669 | 0.640 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2019 | 37 | 0.620 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 373 | 0.590 |
Why?
|
| Drosophila | 8 | 2025 | 829 | 0.550 |
Why?
|
| Parkinson Disease | 1 | 2024 | 740 | 0.520 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 736 | 0.500 |
Why?
|
| Drosophila Proteins | 2 | 2021 | 773 | 0.500 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 535 | 0.500 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1761 | 0.460 |
Why?
|
| Nuclear Proteins | 3 | 2019 | 1347 | 0.430 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1084 | 0.430 |
Why?
|
| Transcription Factors | 3 | 2019 | 2730 | 0.410 |
Why?
|
| Amyloid beta-Peptides | 2 | 2025 | 246 | 0.360 |
Why?
|
| Animals | 15 | 2025 | 36545 | 0.330 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 4807 | 0.260 |
Why?
|
| Drosophila melanogaster | 3 | 2021 | 844 | 0.250 |
Why?
|
| RNA | 2 | 2019 | 606 | 0.240 |
Why?
|
| Clusterin | 1 | 2025 | 11 | 0.240 |
Why?
|
| Astrocytes | 2 | 2025 | 273 | 0.230 |
Why?
|
| Glucosylceramidase | 1 | 2024 | 27 | 0.220 |
Why?
|
| Cell Communication | 1 | 2025 | 188 | 0.220 |
Why?
|
| Coculture Techniques | 1 | 2024 | 247 | 0.210 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 721 | 0.210 |
Why?
|
| Exocytosis | 1 | 2023 | 66 | 0.200 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 621 | 0.190 |
Why?
|
| Alleles | 3 | 2025 | 1716 | 0.190 |
Why?
|
| Sleep Wake Disorders | 1 | 2024 | 187 | 0.180 |
Why?
|
| Lysosomes | 1 | 2023 | 265 | 0.180 |
Why?
|
| Humans | 16 | 2025 | 134083 | 0.180 |
Why?
|
| Peptide Fragments | 1 | 2025 | 834 | 0.170 |
Why?
|
| Animals, Genetically Modified | 2 | 2019 | 344 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 673 | 0.170 |
Why?
|
| Cells, Cultured | 2 | 2024 | 3187 | 0.170 |
Why?
|
| GC Rich Sequence | 1 | 2019 | 6 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 286 | 0.160 |
Why?
|
| Sequence Alignment | 1 | 2021 | 633 | 0.160 |
Why?
|
| Gene Dosage | 1 | 2021 | 458 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 324 | 0.160 |
Why?
|
| RNA Polymerase II | 1 | 2019 | 102 | 0.160 |
Why?
|
| Brain | 2 | 2024 | 3223 | 0.160 |
Why?
|
| Protein Biosynthesis | 2 | 2019 | 678 | 0.150 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 240 | 0.150 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2018 | 13 | 0.150 |
Why?
|
| Heat-Shock Response | 1 | 2018 | 36 | 0.150 |
Why?
|
| Benzimidazoles | 1 | 2018 | 136 | 0.140 |
Why?
|
| Rats | 1 | 2024 | 3890 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 1012 | 0.140 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2794 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1051 | 0.130 |
Why?
|
| Peptides | 1 | 2019 | 862 | 0.120 |
Why?
|
| Mice | 6 | 2025 | 19047 | 0.110 |
Why?
|
| Genome, Human | 1 | 2021 | 1344 | 0.110 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 120 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 825 | 0.100 |
Why?
|
| Glioma | 1 | 2018 | 540 | 0.100 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 67 | 0.100 |
Why?
|
| Myotonic Dystrophy | 1 | 2014 | 151 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2016 | 872 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2013 | 482 | 0.090 |
Why?
|
| Proteins | 1 | 2016 | 1099 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2013 | 375 | 0.080 |
Why?
|
| Female | 6 | 2021 | 71892 | 0.080 |
Why?
|
| Male | 5 | 2021 | 66092 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8617 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 6316 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 399 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2025 | 1878 | 0.060 |
Why?
|
| Infant | 1 | 2021 | 13230 | 0.060 |
Why?
|
| Tauopathies | 1 | 2025 | 78 | 0.050 |
Why?
|
| Transcriptome | 2 | 2025 | 1137 | 0.050 |
Why?
|
| Lipid Peroxides | 1 | 2023 | 15 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2023 | 98 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2025 | 232 | 0.050 |
Why?
|
| Iron | 1 | 2023 | 305 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 169 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 2175 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2539 | 0.040 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2018 | 21 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2019 | 136 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2018 | 116 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 307 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 720 | 0.030 |
Why?
|
| Eye | 1 | 2018 | 245 | 0.030 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2016 | 30 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 915 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2941 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 245 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2014 | 77 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2016 | 288 | 0.030 |
Why?
|
| RNA Stability | 1 | 2014 | 87 | 0.030 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2013 | 69 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2018 | 4934 | 0.030 |
Why?
|
| Stem Cells | 1 | 2018 | 754 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 2911 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 440 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2014 | 378 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2014 | 691 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 406 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 854 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 3796 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 703 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1621 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5217 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 773 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1165 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2013 | 1147 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1923 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2013 | 2044 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 2137 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 4570 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 5086 | 0.010 |
Why?
|